查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1933885

核酸萃取市場（依產品類型、萃取技術、樣品類型和應用分類）－全球預測，2026-2032年

Nucleic Acid Extraction Market by Product Type, Extraction Technique, Sample Type, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年核酸萃取市場規模將達到 41.2 億美元，到 2026 年將成長至 44.3 億美元，到 2032 年將達到 74.8 億美元，年複合成長率為 8.89%。

關鍵市場統計數據
基準年 2025 41.2億美元
預計年份：2026年 44.3億美元
預測年份 2032 74.8億美元
複合年成長率 (%) 8.89%

本文全面介紹了核酸萃取作為分子工作流程基礎的重要性，以及技術、操作和監管要求如何影響各領域解決方案的選擇。

核酸萃取是一項基礎的實驗室操作，它為可靠的下游分子分析（例如基因測序、聚合酵素鏈鎖反應(PCR) 以及越來越多的診斷和研究檢測）提供了基礎。其重要性源於從日益多樣化和複雜的樣本基質中分離高品質 DNA 和 RNA 的需求，因為純度和完整性決定了後續工作流程的敏感度、特異性和可重複性。因此，實驗室相關人員優先考慮那些能夠平衡通量、自動化程度、樣本相容性和監管穩健性的方法，以滿足臨床診斷、轉化研究和藥物發現的技術要求。

自動化、先進化學技術、互通性和基於服務的模式如何共同重塑生命科學領域的核酸提取能力和採購重點

核酸萃取領域正經歷多項技術和操作方面的變革，這些變革正在重新定義實驗室對萃取解決方案的需求。其中最主要的變化是向自動化和高通量能力的轉變，這使得臨床檢查室和中心實驗室能夠在保持檢測性能的同時擴大檢測規模。與自動化並行的是，以微珠為基礎的化學方法也因其穩健性和對各種檢體類型的適應性而備受關注。它既支援可輕鬆整合到機器人系統中的順磁性多粒子珠系統，也支援用於特殊手動處理的非順磁性磁珠工作流程。

評估2025年美國關稅環境如何推動核酸提取生態系統的供應鏈重組、採購調整和策略性近岸外包。

美國在2025年實施的新關稅，使得核酸萃取設備、試劑及相關耗材的全球供應鏈變得更加複雜。關稅導致進口零件和成品成本上升，迫使製造商和經銷商重新評估其籌資策略，許多企業正在加速供應商多元化，並評估近岸外包和國內生產的可能性，以降低風險。這些策略性因應措施反映了企業在成本最佳化和供應鏈韌性之間尋求平衡的更廣泛趨勢，並將對採購週期和合約結構產生直接影響。

深度細分分析揭示了產品類型、提取技術、應用、最終用戶和檢體分類如何決定技術需求和商業化策略。

細分市場層面的趨勢揭示了不同產品類型、萃取技術、應用、終端用戶和樣品類別之間截然不同的性能和應用模式，每種模式都需要獨特的技術解決方案和商業化方法。產品系列涵蓋儀器、試劑組和服務。儀器種類繁多，從專為低通量實驗室設計的桌上型系統到用於集中檢測機構的高通量平台，應有盡有。試劑組依工作流程自動化程度的不同，提供自動化和手動兩種形式。服務包括客製化萃取服務和樣品製備服務，旨在幫助不具備內部能力的客戶。萃取技術同樣多種多樣。以微珠為基礎法具有靈活性，可使用各種順磁性磁珠輕鬆整合到自動化工作流程中，也可使用非順磁性磁珠進行專門的手動通訊協定。沉澱法分為醇基沉澱法和鹽基沉澱法，二者在純度和產率方面各有優劣。旋轉柱系統採用聚合物基膜或矽膠膜，針對不同的結合和清潔性能進行了最佳化。

區域分析表明，主要全球市場中不同的管理體制、基礎設施成熟度和供應鏈優先事項如何導致不同的採用模式。

區域趨勢揭示了美洲、歐洲、中東和非洲以及亞太市場在產品應用路徑和投資重點方面存在的差異化促進因素和限制因素。在美洲，強勁的臨床診斷需求和成熟的研究生態系統推動了對自動化和整合工作流程的投資，而採購決策則受到報銷政策和醫療基礎設施差異的影響。作為重要的研發和臨床檢測中心，美國高度重視監管檢驗、快速結果報告以及與檢查室IT系統的互通性，因此更傾向於選擇性能可靠且售後服務完善的儀器和試劑組。

競爭評估重點闡述了智慧財產權、平台套件合作夥伴關係、區域服務網路和監管合規如何創造永續的商業性優勢。

領先供應商之間的競爭動態凸顯了技術差異化、策略夥伴關係和服務整合的重要性。那些投資於強大的智慧財產權組合（尤其是在萃取化學技術和儀器自動化介面方面）的市場參與企業，能夠透過與下游分析平台的緊密整合來鞏固自身地位。儀器製造商和試劑開發人員之間的合作已成為一種普遍趨勢，預先檢驗的試劑盒和平台組合能夠減輕客戶的檢驗負擔，並加速其在臨床和研究環境中的應用。此外，越來越多的公司正在探索以服務主導的交付模式，為尋求承包解決方案和擴充性但又不想進行大量資本投入的機構提供客製化的萃取解決方案和工作流程管理。

製造商和供應商提升產品適應性、供應彈性、服務品質和臨床檢驗以實現永續成長的實用策略

為了掌握核酸萃取領域不斷成長的機遇，產業領導者應採取多管齊下的策略，平衡技術創新、供應鏈韌性和以客戶為中心的服務模式。優先發展模組化自動化架構，使其既能支援桌上型操作的柔軟性，擴充性的高通量配置需求，從而實現跨領域的吸引力，從就地檢驗實驗室到集中式檢測中心均能適用。同時，也應投資於自動化試劑盒和手動試劑盒之間的試劑相容性，以減少客戶鎖定，並促進檢查室在工作流程模式變更時實現平穩過渡。

本報告的調查方法說明一手訪談、第二手資料檢驗、細分調整和詳細的檢驗流程，以確保提供可操作且可靠的市場洞察。

本報告的研究融合了定性訪談、文獻綜述和系統性細分映射，以確保分析的嚴謹性和透明度。主要數據是透過對來自臨床、研究和商業機構的檢查室經理、採購人員、研發科學家和法規專家進行結構化和半結構化訪談收集的，旨在提供關於營運挑戰、採購標準和技術偏好的實證觀點。包括同儕審查文獻、技術白皮書、法規指導文件和供應商技術規格第二手資料，檢驗並強化了訪談結果。

簡明扼要地總結了技術進步、營運韌性和策略夥伴關係將如何決定核酸萃取領域的長期領導地位。

核酸萃取仍然是現代分子生物學、診斷學和治療研發中至關重要的基礎技術。自動化、先進的萃取化學技術和以服務為導向的供應模式的相互作用，正在催生一個以技術性能、互通性和供應鏈韌性為長期成功關鍵的市場。實驗室和生命科學機構日益尋求能夠處理從血漿、血清到福馬林固定石蠟包埋（FFPE）組織等多種檢體類型的解決方案，同時還要能夠無縫整合到更廣泛的實驗室工作流程和品管框架中。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依產品類型分類的核酸萃取市場

  • 裝置
    • 桌上型系統
    • 高通量系統
  • 試劑組
    • 自動化套件
    • 手冊套件
  • 服務
    • 客製化提取服務
    • 樣品製備服務

第9章 核酸萃取市場（依萃取技術分類）

  • 以微珠為基礎的
    • 高磁性珠子
    • 順磁性珠子
  • 降水法
    • 酒精沉澱
    • 鹽析法
  • 旋轉柱
    • 聚合物基膜
    • 二氧化矽膜

第10章 依檢體類型分類的核酸萃取市場

  • 血液樣本
    • 電漿
    • 血清
    • 全血
  • 細胞樣本
    • 培養細胞
    • 原代細胞
  • 組織樣本
    • FFPE組織
    • 新鮮紙巾

第11章 核酸萃取市場：依應用領域分類

  • 臨床診斷
    • 基因檢測
    • 傳染病檢查
  • 法醫分析
    • 犯罪現場調查
    • 親子鑑定
  • 藥物研發
    • 生物標記開發
    • 藥物發現
  • 研究
    • 基因組研究
    • 轉錄組學調查

第12章 核酸萃取市場：依地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 核酸萃取市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國核酸萃取市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國核酸萃取市場

第16章 中國核酸萃取市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • Analytik Jena AG
  • Bio-Rad Laboratories, Inc.
  • BioMerieux SA
  • Bioneer Corporation
  • Danaher Corporation
  • Eppendorf AG
  • Hamilton Company
  • Hologic, Inc.
  • Illumina, Inc.
  • Kurabo Biomedical
  • LGC Biosearch Technologies
  • Lucigen Corporation
  • Macherey-Nagel GmbH & Co. KG
  • Merck KGaA
  • New England Biolabs
  • Norgen Biotek Corp.
  • Omega Bio-Tek, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Roche Diagnostics International AG
  • Takara Bio Inc.
  • Tecan Group Ltd
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corporation
Product Code: MRR-C36616F699A3

The Nucleic Acid Extraction Market was valued at USD 4.12 billion in 2025 and is projected to grow to USD 4.43 billion in 2026, with a CAGR of 8.89%, reaching USD 7.48 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.12 billion
Estimated Year [2026] USD 4.43 billion
Forecast Year [2032] USD 7.48 billion
CAGR (%) 8.89%

Comprehensive introduction to why nucleic acid extraction underpins molecular workflows and how technical, operational, and regulatory demands shape solution selection across sectors

Nucleic acid extraction serves as the foundational laboratory process that enables reliable downstream molecular analyses, including genomic sequencing, polymerase chain reaction, and a growing array of diagnostic and research assays. Its centrality stems from the need to isolate high-quality DNA and RNA from increasingly diverse and complex sample matrices, where purity and integrity determine the sensitivity, specificity, and reproducibility of subsequent workflows. Laboratory stakeholders therefore prioritize methods that balance throughput, automation, sample compatibility, and regulatory robustness to meet the technical demands of clinical diagnostics, translational research, and pharmaceutical discovery.

Operational realities are shaping how extraction solutions are evaluated and adopted. Laboratories that process clinical specimens must contend with chain-of-custody requirements and validated workflows, while academic and industrial research groups often require flexible protocols that accommodate novel sample types and experimental designs. Additionally, the integration of extraction platforms with laboratory information systems and automation suites is driving preference for modular solutions that support seamless data capture and traceability. As a result, product portfolios span bench-top instruments and high-throughput systems, reagent kits optimized for manual and automated processing, and a spectrum of services that include custom extraction and sample preparation support.

End users differ in their demands, whether focused on blood-derived biomarkers, cultured cell inputs, or formalin-fixed paraffin-embedded tissue, which necessitates a nuanced appreciation of sample-specific extraction chemistries and device designs. Emerging applications, such as single-cell and transcriptomic studies, place heightened emphasis on low-input recovery and minimal degradation, while forensic and public health contexts emphasize robustness across degraded or low-abundance samples. Collectively, these vectors of technical need and operational constraint frame a market where innovation is driven by a combination of scientific rigor, workflow efficiency, and regulatory compliance.

How automation, advanced chemistries, interoperability, and service-based models are jointly reshaping nucleic acid extraction capabilities and procurement priorities across the life sciences

The landscape for nucleic acid extraction is evolving through several convergent technological and operational shifts that are redefining what laboratories expect from extraction solutions. Foremost among these shifts is the move toward automation and high-throughput capacity, which enables clinical laboratories and central testing facilities to scale testing volumes while preserving assay performance. Alongside automation, magnetic bead-based chemistries are gaining traction due to their robustness and adaptability across sample types, supporting both paramagnetic bead systems that integrate readily with robotics and non-paramagnetic bead workflows for specialized manual handling.

Another transformative change is the refinement of membrane and column chemistries. Advances in polymer-based and silica membrane technologies have improved nucleic acid binding efficiency and inhibitor removal, which benefits downstream applications like next-generation sequencing and diagnostic PCR. These developments are complemented by reagent kit innovations that target both automated platforms and manual protocols, ensuring laboratories of varying resource levels can match extraction performance to operational constraints.

Interoperability across the lab ecosystem is also reshaping procurement decisions. Instruments and reagent kits that align with laboratory information management systems, sample tracking protocols, and quality-control frameworks command preference because they reduce integration friction and support compliance. In parallel, an expanded role for service providers has emerged; custom extraction services and specialized sample-preparation offerings now support organizations that lack in-house capacity or require bespoke protocols for complex matrices. Taken together, these shifts are creating an environment in which agility, scalability, and integration capability distinguish leading solutions, and where the pace of incremental innovation is accelerating in response to both scientific advances and evolving healthcare priorities.

Assessment of how the 2025 United States tariff landscape is driving supply chain realignment, procurement adaptation, and strategic nearshoring across nucleic acid extraction ecosystems

The introduction of new tariff measures in the United States in 2025 has introduced a layer of complexity across global supply chains for nucleic acid extraction instruments, reagents, and ancillary consumables. Tariff-related cost increases for imported components and finished products have prompted manufacturers and distributors to reassess sourcing strategies, with many accelerating supplier diversification efforts and evaluating nearshoring or domestic manufacturing to mitigate exposure. These strategic responses reflect a broader recalibration of supply resilience versus cost optimization that has immediate implications for procurement timelines and contractual arrangements.

Tariffs have also influenced pricing dynamics along the distribution channel. End users report lengthened negotiations as suppliers seek to absorb some tariff impacts while preserving margins and quality standards. The pressure is most acute for capital-intensive bench-top and high-throughput instruments where component tariffs cascade into higher list prices or extended lead times as manufacturers retool procurement. Reagent kits, particularly those reliant on specialized enzymes and proprietary chemistries sourced internationally, have seen tighter inventory management practices as distributors prioritize continuity of supply for critical clinical and research customers.

Policy-driven trade barriers have accelerated strategic partnerships and regional alliances, as vendors pursue mutually beneficial arrangements to secure component access and optimize logistics. In response, service providers offering custom extraction and sample-preparation capabilities are increasingly positioning themselves as local partners to hedge tariff-related uncertainty, enabling laboratories to maintain continuity without committing to large capital expenditures. Regulatory agencies and accreditation bodies are simultaneously adapting guidance on supply chain documentation and validation requirements, emphasizing transparency around sourcing and change control for validated workflows. Ultimately, the tariff environment is catalyzing structural adjustments across procurement, manufacturing footprint, and service models, making supply chain resilience a critical component of vendor evaluation and institutional risk management.

Deep segmentation insight revealing how product types, extraction techniques, applications, end users, and sample classes determine technical requirements and commercialization strategies

Segment-level dynamics reveal nuanced performance and adoption patterns across product types, extraction techniques, applications, end users, and sample categories, each demanding distinct technical solutions and commercialization approaches. Product portfolios span instruments, reagent kits, and services, where instruments encompass bench-top systems tailored for lower throughput laboratories and high-throughput platforms designed for centralized testing facilities, reagent kits differentiate between automated and manual formats to suit varying workflow automation degrees, and services include both custom extraction engagements and sample-preparation offerings that support clients without in-house capacity. Extraction technique choices are similarly diverse: magnetic bead-based methods provide adaptability with paramagnetic bead variants that readily integrate into robotic workflows and non-paramagnetic options used in specialized manual protocols, precipitation approaches divide into alcohol-based and salt-based chemistries offering different purity and yield trade-offs, and spin column systems rely on either polymer-based or silica membranes optimized for distinct binding and wash characteristics.

Application-driven requirements strongly influence product configuration and support models. Clinical diagnostics demand validated procedures for genetic testing and infectious disease testing with strict quality controls and traceability, forensic analysis prioritizes workflows capable of handling degraded or limited samples for crime scene investigation and paternity testing, pharmaceutical development focuses on reproducible extraction for biomarker discovery and drug discovery pipelines, and research settings require flexibility for genomics and transcriptomics research that may entail low-input or single-cell workflows. End users reflect a spectrum of operational contexts: academic and research institutes encompass research centers and universities with diverse protocol needs and budgetary constraints, diagnostic laboratories include both central labs and point-of-care facilities with differing throughput profiles, hospitals and clinics operate across private clinics and public hospitals where regulatory and procurement environments vary, and pharmaceutical and biotechnology companies consist of large-scale pharmaceutical enterprises and more agile biotech firms pursuing translational and discovery programs.

Sample-type considerations further shape product and service offerings. Blood-derived inputs, including plasma, serum, and whole blood, require chemistries that preserve nucleic acid integrity while minimizing inhibitors; cell samples comprised of cultured cells and primary cells demand gentle lysis and efficient recovery to support downstream assays; and tissue samples present distinct challenges where FFPE tissue necessitates deparaffinization and damage reversal protocols, while fresh tissue benefits from rapid stabilization approaches. Vendors and service providers that align product capabilities and support services to these segmentation layers-offering validated protocols, modular instrument compatibility, and targeted training-are positioned to address a broad set of customer needs while differentiating through technical depth and operational support.

Regional analysis showing how distinct regulatory regimes, infrastructure maturity, and supply chain priorities drive differentiated adoption patterns across major global markets

Regional dynamics exhibit differentiated drivers and constraints that shape adoption pathways and investment priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific markets. In the Americas, strong clinical diagnostics demand and a mature research ecosystem incentivize investment in automation and integrated workflows, with procurement decisions influenced by reimbursement policies and healthcare infrastructure variability. The United States, as a significant R&D and clinical testing hub, emphasizes regulatory validation, rapid turnaround, and interoperability with laboratory IT systems, which in turn drives preference for instruments and reagent kits with proven performance and service backstops.

In Europe, Middle East & Africa, regulatory heterogeneity and a mix of centralized and decentralized laboratory networks create a market where modular solutions and adaptable service models gain traction. Compliance with regional standards and localized validation pathways is a prevailing consideration, and partnerships with regional distributors and service providers facilitate market entry and support. Across the Asia-Pacific region, rapid expansion of molecular diagnostics, a growing biotechnology sector, and increasing investment in genomic and public-health infrastructure are accelerating uptake of both high-throughput systems for centralized facilities and compact bench-top platforms for decentralized testing. Local manufacturing and regional supply chain development have also become strategic priorities in Asia-Pacific, reflecting efforts to balance cost-efficiency with supply reliability.

These regional differences inform vendor go-to-market strategies and service offerings. Companies that tailor their sales models, validation support, and training programs to regional regulatory frameworks and laboratory capabilities can capture opportunities more effectively. Furthermore, regional supply chain considerations, including proximity to component suppliers and logistics networks, influence lead times and total cost of ownership, prompting buyers and vendors alike to weigh local presence and service coverage as key criteria when selecting extraction platforms and reagent partners.

Competitive landscape assessment highlighting how intellectual property, platform-kit partnerships, regional service networks, and regulatory validation create enduring commercial advantages

Competitive dynamics among leading providers emphasize technological differentiation, strategic partnerships, and service integration. Market participants that invest in robust intellectual property portfolios, particularly around extraction chemistries and instrument automation interfaces, secure defensible positions by enabling tighter integration with downstream analytical platforms. Collaboration between instrument manufacturers and reagent developers is a recurring motif, as pre-validated kit-platform pairings reduce customer validation burdens and accelerate adoption across clinical and research settings. Additionally, an increasing number of companies pursue service-led offerings, supplying custom extraction solutions and managed workflows to institutions seeking turn-key capabilities or scalability without capital-intensive commitments.

Strategic activity also focuses on expanding geographic footprints and strengthening after-sales support networks to address regional service expectations and minimize instrument downtime. Partnerships with local distributors and the establishment of regional technical centers serve to shorten response times and enhance training capacity, which are critical value drivers for clinical laboratories operating under accreditation constraints. Investment in digital enablement, including remote diagnostics and predictive maintenance for instruments, further differentiates providers by improving uptime and facilitating more predictable operational planning for laboratory managers.

Finally, companies that demonstrate regulatory acumen and publish validation data for clinical contexts tend to build trust with diagnostic laboratories and healthcare systems. Transparent documentation of performance across sample types, adherence to change-control protocols, and provision of comprehensive training and quality-assurance resources increase vendor credibility and foster long-term relationships with high-value customers in pharmaceuticals, hospitals, and centralized testing facilities.

Practical strategic recommendations for manufacturers and suppliers to enhance product adaptability, supply resilience, service excellence, and clinical validation for sustainable growth

Industry leaders should pursue a multi-pronged strategy that balances technological innovation, supply chain resilience, and customer-centric service models to capture expanding opportunities in nucleic acid extraction. Prioritize modular automation architectures that support both bench-top flexibility and scalable high-throughput configurations, enabling cross-segment appeal from point-of-care labs to centralized testing centers. Concurrently, invest in reagent compatibility across automated and manual kits to reduce customer lock-in friction and to facilitate transitions between workflow modalities as laboratory needs evolve.

Strengthen supply chain strategies by diversifying suppliers, qualifying alternative component sources, and exploring regional manufacturing partnerships to mitigate tariff and logistics risks. Embed robust change-control and validation protocols into supply agreements to reassure customers and regulators about continuity of performance. Enhance service and support capabilities by establishing regional technical hubs, expanding training programs, and offering managed service options for customers preferring to outsource extraction workflows. These measures will reduce downtime risk and differentiate offerings on the basis of total operational value rather than price alone.

Finally, deepen scientific and clinical collaborations to generate peer-reviewed validation studies and real-world evidence across relevant sample types and applications. Collaborate with end users in academic, clinical, and pharmaceutical settings to co-develop protocols that address challenging matrices such as FFPE tissue or low-input single-cell samples. Use these partnerships to build compelling clinical utility narratives that facilitate adoption in regulated environments and to inform roadmap decisions that prioritize features delivering measurable laboratory efficiencies and assay improvements.

Rigorous research methodology detailing primary interviews, secondary evidence triangulation, segmentation alignment, and validation processes to ensure actionable and credible market intelligence

The research underpinning this report blends primary qualitative interviews, secondary literature synthesis, and methodical segmentation mapping to ensure analytical rigor and transparency. Primary inputs were obtained through structured and semi-structured interviews with laboratory managers, procurement leaders, R&D scientists, and regulatory specialists across clinical, research, and commercial organizations, providing grounded perspectives on operational challenges, procurement criteria, and technology preferences. Secondary material included peer-reviewed literature, technical white papers, regulatory guidance documents, and supplier technical specifications to validate and augment insights derived from interviews.

Data triangulation was applied across sources to corroborate thematic findings and to identify consistent patterns regarding technology adoption, sample-specific requirements, and regional procurement dynamics. The segmentation framework was developed iteratively, aligning product type, extraction technique, application, end-user, and sample-type categorizations with real-world purchasing and laboratory workflows to enhance relevance for decision-makers. Where appropriate, sensitivity analyses explored how external factors such as trade policy shifts and supply chain disruptions could alter vendor strategies and customer procurement behavior.

Limitations of the methodology are acknowledged, particularly the variability inherent in regional regulatory regimes and the rapid pace of technological innovation that can change vendor positioning between reporting cycles. The research mitigated these limitations through repeated validation with subject-matter experts and by focusing on durable structural trends rather than short-lived market fluctuations. All primary research participants were engaged under confidentiality terms, and qualitative findings were aggregated to preserve anonymity while delivering actionable insight.

Concise conclusion synthesizing how technological advances, operational resilience, and strategic partnerships will determine long-term leadership in nucleic acid extraction

Nucleic acid extraction remains a pivotal enabler of modern molecular biology, diagnostics, and therapeutic development. The interplay of automation, advanced extraction chemistries, and service-oriented delivery models has created a market where technical performance, interoperability, and supply chain resilience determine long-term success. Laboratories and life-science organizations are increasingly demanding solutions that can handle diverse sample types-from plasma and serum to FFPE tissue-while integrating seamlessly into broader laboratory workflows and quality frameworks.

At the vendor level, advantages accrue to those who couple platform innovation with reagent compatibility, robust regional service networks, and clear regulatory documentation. Meanwhile, policy shifts and trade measures emphasize the importance of strategic sourcing and regional manufacturing strategies to preserve supply continuity. For decision-makers, the priority is to select partners that not only meet immediate technical specifications but also provide the operational support and validation resources necessary for sustainable deployment across clinical, research, and industrial settings. The cumulative effect of these trends points toward an ecosystem that rewards agility, scientific depth, and customer-centric service models.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nucleic Acid Extraction Market, by Product Type

  • 8.1. Instruments
    • 8.1.1. Bench-Top Systems
    • 8.1.2. High-Throughput Systems
  • 8.2. Reagent Kits
    • 8.2.1. Automated Kits
    • 8.2.2. Manual Kits
  • 8.3. Services
    • 8.3.1. Custom Extraction Services
    • 8.3.2. Sample Preparation Services

9. Nucleic Acid Extraction Market, by Extraction Technique

  • 9.1. Magnetic Bead Based
    • 9.1.1. Non-Paramagnetic Beads
    • 9.1.2. Paramagnetic Beads
  • 9.2. Precipitation
    • 9.2.1. Alcohol Precipitation
    • 9.2.2. Salt Precipitation
  • 9.3. Spin Column
    • 9.3.1. Polymer-Based Membrane
    • 9.3.2. Silica Membrane

10. Nucleic Acid Extraction Market, by Sample Type

  • 10.1. Blood Samples
    • 10.1.1. Plasma
    • 10.1.2. Serum
    • 10.1.3. Whole Blood
  • 10.2. Cell Samples
    • 10.2.1. Cultured Cells
    • 10.2.2. Primary Cells
  • 10.3. Tissue Samples
    • 10.3.1. FFPE Tissue
    • 10.3.2. Fresh Tissue

11. Nucleic Acid Extraction Market, by Application

  • 11.1. Clinical Diagnostics
    • 11.1.1. Genetic Testing
    • 11.1.2. Infectious Disease Testing
  • 11.2. Forensic Analysis
    • 11.2.1. Crime Scene Investigation
    • 11.2.2. Paternity Testing
  • 11.3. Pharmaceutical Development
    • 11.3.1. Biomarker Development
    • 11.3.2. Drug Discovery
  • 11.4. Research
    • 11.4.1. Genomics Research
    • 11.4.2. Transcriptomics Research

12. Nucleic Acid Extraction Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Nucleic Acid Extraction Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Nucleic Acid Extraction Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Nucleic Acid Extraction Market

16. China Nucleic Acid Extraction Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agilent Technologies, Inc.
  • 17.6. Analytik Jena AG
  • 17.7. Bio-Rad Laboratories, Inc.
  • 17.8. BioMerieux SA
  • 17.9. Bioneer Corporation
  • 17.10. Danaher Corporation
  • 17.11. Eppendorf AG
  • 17.12. Hamilton Company
  • 17.13. Hologic, Inc.
  • 17.14. Illumina, Inc.
  • 17.15. Kurabo Biomedical
  • 17.16. LGC Biosearch Technologies
  • 17.17. Lucigen Corporation
  • 17.18. Macherey-Nagel GmbH & Co. KG
  • 17.19. Merck KGaA
  • 17.20. New England Biolabs
  • 17.21. Norgen Biotek Corp.
  • 17.22. Omega Bio-Tek, Inc.
  • 17.23. PerkinElmer, Inc.
  • 17.24. Promega Corporation
  • 17.25. QIAGEN N.V.
  • 17.26. Roche Diagnostics International AG
  • 17.27. Takara Bio Inc.
  • 17.28. Tecan Group Ltd
  • 17.29. Thermo Fisher Scientific Inc.
  • 17.30. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NUCLEIC ACID EXTRACTION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NUCLEIC ACID EXTRACTION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY EXTRACTION TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES NUCLEIC ACID EXTRACTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA NUCLEIC ACID EXTRACTION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY BENCH-TOP SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY BENCH-TOP SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY BENCH-TOP SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY HIGH-THROUGHPUT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY HIGH-THROUGHPUT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY HIGH-THROUGHPUT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY REAGENT KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY REAGENT KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY REAGENT KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY REAGENT KITS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY AUTOMATED KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY AUTOMATED KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY AUTOMATED KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY MANUAL KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY MANUAL KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY MANUAL KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SAMPLE PREPARATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SAMPLE PREPARATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SAMPLE PREPARATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY EXTRACTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY NON-PARAMAGNETIC BEADS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY NON-PARAMAGNETIC BEADS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY NON-PARAMAGNETIC BEADS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PARAMAGNETIC BEADS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PARAMAGNETIC BEADS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PARAMAGNETIC BEADS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRECIPITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRECIPITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRECIPITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRECIPITATION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY ALCOHOL PRECIPITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY ALCOHOL PRECIPITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY ALCOHOL PRECIPITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SALT PRECIPITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SALT PRECIPITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SALT PRECIPITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SPIN COLUMN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SPIN COLUMN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SPIN COLUMN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SPIN COLUMN, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY POLYMER-BASED MEMBRANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY POLYMER-BASED MEMBRANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY POLYMER-BASED MEMBRANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SILICA MEMBRANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SILICA MEMBRANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SILICA MEMBRANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY BLOOD SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY BLOOD SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY BLOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CELL SAMPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CELL SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CELL SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CELL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CULTURED CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CULTURED CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CULTURED CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRIMARY CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRIMARY CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRIMARY CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY TISSUE SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY TISSUE SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY FFPE TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY FFPE TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY FFPE TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY FRESH TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY FRESH TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY FRESH TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY FORENSIC ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY FORENSIC ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY FORENSIC ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY FORENSIC ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CRIME SCENE INVESTIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CRIME SCENE INVESTIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY CRIME SCENE INVESTIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PATERNITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PATERNITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PATERNITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PHARMACEUTICAL DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PHARMACEUTICAL DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PHARMACEUTICAL DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY PHARMACEUTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY BIOMARKER DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY BIOMARKER DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY BIOMARKER DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY GENOMICS RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY GENOMICS RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY GENOMICS RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY TRANSCRIPTOMICS RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY TRANSCRIPTOMICS RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY TRANSCRIPTOMICS RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY REAGENT KITS, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY EXTRACTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRECIPITATION, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY SPIN COLUMN, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY BLOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY CELL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY FORENSIC ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY PHARMACEUTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS NUCLEIC ACID EXTRACTION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY REAGENT KITS, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY EXTRACTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRECIPITATION, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY SPIN COLUMN, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY BLOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY CELL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY FORENSIC ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY PHARMACEUTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY REAGENT KITS, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY EXTRACTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRECIPITATION, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY SPIN COLUMN, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY BLOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY CELL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY FORENSIC ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY PHARMACEUTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY REAGENT KITS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY EXTRACTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRECIPITATION, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY SPIN COLUMN, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY BLOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY CELL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY FORENSIC ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY PHARMACEUTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY REAGENT KITS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY EXTRACTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRECIPITATION, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY SPIN COLUMN, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY BLOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY CELL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY FORENSIC ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY PHARMACEUTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE NUCLEIC ACID EXTRACTION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY REAGENT KITS, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY EXTRACTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRECIPITATION, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY SPIN COLUMN, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY BLOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY CELL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY FORENSIC ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY PHARMACEUTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST NUCLEIC ACID EXTRACTION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY REAGENT KITS, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY EXTRACTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRECIPITATION, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY SPIN COLUMN, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY BLOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY CELL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY FORENSIC ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY PHARMACEUTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA NUCLEIC ACID EXTRACTION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY REAGENT KITS, 2018-2032 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY EXTRACTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRECIPITATION, 2018-2032 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY SPIN COLUMN, 2018-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY BLOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY CELL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY FORENSIC ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY PHARMACEUTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC NUCLEIC ACID EXTRACTION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 284. GLOBAL NUCLEIC ACID EXTRACTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY REAGENT KITS, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 290. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY EXTRACTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 291. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 292. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRECIPITATION, 2018-2032 (USD MILLION)
  • TABLE 293. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY SPIN COLUMN, 2018-2032 (USD MILLION)
  • TABLE 294. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY BLOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 296. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY CELL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 297. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY TISSUE SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 298. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 299. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 300. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY FORENSIC ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 301. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY PHARMACEUTICAL DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 302. ASEAN NUCLEIC ACID EXTRACTION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 303. GCC NUCLEIC ACID EXTRACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 304. GCC NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. GCC NUCLEIC ACID EXTRACTION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 306. GCC NUCLEIC ACID EXTRACTION MARKET SIZE, BY REAGENT KITS, 2018-2032 (USD MILLION)
  • TABLE 307. GCC NUCLEIC ACID EXTRACTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 308. GCC NUCLEIC ACID EXTRACTION MARKET SIZE, BY EXTRACTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 309. GCC NUCLEIC ACID EXTRACTION MARKET SIZE, BY MAGNETIC BEAD BASED, 2018-2032 (USD MILLION)
  • TABLE 310. GCC NUCLEIC ACID EXTRACTION MARKET SIZE, BY PRECIPITATION, 2018-2032 (USD MILLION)
  • TABLE 311. GCC NUCLEIC ACID EXTRACTION MARKET SIZE, BY SPIN COLUMN, 2018-2032 (USD MILLION)
  • TABLE 312. GCC NUCLEIC ACID EXTRACTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (